Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Rapid Nutrition PLC (EM) RPNRD


Primary Symbol: RPNRF

Rapid Nutrition PLC, a natural healthcare company, develops and distributes science-based health and wellness products worldwide. The company offers natural and organic ingredients designed for weight loss under the System LS brand; herbal medicine for symptoms of sore throat, colds, and flu, as well as added Ashwagandha and Andrographis for strong immunity boost for travelers under the Azurene brand. It also provides products under the third-party brands. Rapid Nutrition PLC was founded in 2001 and is based in Mildenhall, the United Kingdom.


EXPM:RPNRF - Post by User

Bullboard Posts
User Avatar Image
(14)
•••
  • AveragePennyX
Post by AveragePennyon Aug 31, 2021 10:48am
130 Views
Post# 33787592

RPNRF David Hunter Joins Rapid Nutrition

RPNRF David Hunter Joins Rapid Nutritionhttps://www.accesswire.com/662117/university-of-sydney-professor-and-rheumatology-researcher-david-hunter-joins-rapid-nutrition-scientific-advisory-board

Dr. Hunter also serves on the editorial board for Arthritis and Rheumatology, Osteoarthritis and Cartilage, Arthritis Care and Research and is part of the review committee for the American College of Rheumatology, EULAR and OARSI scientific meetings. He has more than 500 peer-reviewed publications in international journals and has co-authored several books. He received the OARSI Clinical Researcher Award in 2019 as well as the Vice-Chancellor's Award for Research Excellence and the Distinguished Professorial Achievement Award at the University of Sydney.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities